PhD in Biopharmacy, with 7 years of experience in nanomedicine, I specialize in formulating oligonucleotides and small molecules in both polymer and lipid nanoparticles. Trained in orthogonal method characterization by EU NCL, I currently serve as Communication Chair for the Controlled Release Society's Gene Delivery and Editing Focus Group. My expertise includes utilizing diverse techniques such as DLS, NTA, AF4-DLS, TEM, SEM, izon, nanoFCM, and more to optimize critical quality attributes like size, charge and encapsulation efficiency. I offer support to PhD students and industry professionals, providing guidance on formulation optimization and regulatory compliance in nanomedicine.